Edap Tms (NASDAQ:EDAP) Given New $4.50 Price Target at Piper Sandler

Edap Tms (NASDAQ:EDAP) had its target price reduced by Piper Sandler from $5.00 to $4.50 in a research note released on Friday morning,Benzinga reports. They currently have an overweight rating on the medical equipment provider’s stock.

EDAP has been the subject of several other reports. HC Wainwright restated a “buy” rating and set a $19.00 target price on shares of Edap Tms in a report on Friday. StockNews.com initiated coverage on shares of Edap Tms in a report on Friday. They set a “hold” rating for the company.

Edap Tms Stock Performance

NASDAQ:EDAP opened at $2.15 on Friday. The company has a market capitalization of $79.77 million, a price-to-earnings ratio of -3.31 and a beta of 0.37. The company has a debt-to-equity ratio of 0.08, a current ratio of 2.18 and a quick ratio of 1.46. Edap Tms has a 1-year low of $1.96 and a 1-year high of $8.50. The business has a 50 day moving average of $2.42 and a 200 day moving average of $2.51.

Edap Tms (NASDAQ:EDAP) last issued its earnings results on Thursday, March 27th. The medical equipment provider reported ($0.05) EPS for the quarter, topping analysts’ consensus estimates of ($0.11) by $0.06. Edap Tms had a negative net margin of 34.92% and a negative return on equity of 44.21%. The company had revenue of $22.69 million for the quarter, compared to analysts’ expectations of $20.83 million. On average, sell-side analysts predict that Edap Tms will post -0.6 earnings per share for the current fiscal year.

Institutional Trading of Edap Tms

Large investors have recently added to or reduced their stakes in the stock. BNP Paribas Financial Markets increased its position in shares of Edap Tms by 23.7% during the third quarter. BNP Paribas Financial Markets now owns 23,000 shares of the medical equipment provider’s stock valued at $59,000 after buying an additional 4,400 shares during the period. Parkman Healthcare Partners LLC purchased a new position in Edap Tms during the 3rd quarter valued at about $395,000. Orion Capital Management LLC boosted its stake in Edap Tms by 10.4% during the third quarter. Orion Capital Management LLC now owns 69,800 shares of the medical equipment provider’s stock worth $178,000 after acquiring an additional 6,600 shares in the last quarter. Illumine Investment Management LLC purchased a new stake in Edap Tms in the fourth quarter worth about $50,000. Finally, Rock Springs Capital Management LP increased its stake in shares of Edap Tms by 1.5% during the fourth quarter. Rock Springs Capital Management LP now owns 1,591,800 shares of the medical equipment provider’s stock valued at $3,518,000 after purchasing an additional 23,800 shares in the last quarter. Institutional investors own 62.74% of the company’s stock.

About Edap Tms

EDAP TMS SA is a holding company, which, through its subsidiary, engages in the development, production, and marketing of minimally invasive medical devices for urological diseases. It operates through the High Intensity Focused Ultrasound (HIFU) and Urology Devices and Services (UDS) segments. The HIFU segment develops, manufactures, and markets devices for the minimally invasive ablation of certain types of localized tumors using HIFU technology.